Optimizing drug delivery for enhancing therapeutic efficacy of recombinant human endostatin in cancer treatment

Critical Reviews in Therapeutic Drug Carrier Systems
Fuguo XuHuanchen Sha

Abstract

Recombinant human endostatin (rhEndostatin) is uniquely able to target neovascular endothelial cells (ECs) and has the potential for antiangiogenetic and antitumor activities. In this review, we explore experimental approaches and clinical trials focusing on drug delivery of endostatin. Continued endostatin therapy can maintain tumors in a state of dormancy, and no signs of drug-induced resistance have been observed. Prolonged delivery of endostatin may be achieved by using pumps (mini-osmotic pumps) or cell encapsulation systems. The largest benefit from rhEndostatin is expected when drug delivery of rhEndostatin is begun as early as possible. Although endostatin has shown promise in controlling tumor neovasculature, a major problem in pharmacotherapy is the side effects of constant drug administration and the limited half-life of antiangiogenic proteins. Gene therapy offers the advantages of maximizing cost effectiveness and maintaining sustained levels of antiangiogenic factors, which may enhance antitumor efficacy. Therefore, we have investigated recent advances in gene delivery of endostatin for cancer treatment. In recent years, preclinical and clinical data have demonstrated the synergistic effects of rhEndostatin combin...Continue Reading

Citations

Dec 21, 2010·International Journal of Nanomedicine·Sanyuan Hu, Yangde Zhang
Apr 17, 2009·Expert Opinion on Biological Therapy·Michalis V Karamouzis, Stergios J Moschos
Feb 13, 2016·Frontiers in Pharmacology·Sylvie Ricard-Blum, Sylvain D Vallet
Sep 14, 2010·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Ambra Pozzi, Roy Zent
Aug 7, 2013·Paediatric Drugs·Edwin A Lomotan, Denise Dougherty
Sep 2, 2017·Nuclear Medicine Communications·Chuanwang MiaoXudong Hu

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

Minimally Invasive Therapy & Allied Technologies : MITAT : Official Journal of the Society for Minimally Invasive Therapy
V RaffaA Cuschieri
The Journal of Pharmacy and Pharmacology
L Harivardhan Reddy
International Journal of Cancer. Journal International Du Cancer
Jean BénardDaniel Satgé
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Tong-Young LeeKashi Javaherian
© 2021 Meta ULC. All rights reserved